Neutralizing Monoclonal Antibodies as Promising Therapeutics against Middle East Respiratory Syndrome Coronavirus Infection

Neutralizing Monoclonal Antibodies as Promising Therapeutics against Middle East Respiratory Syndrome Coronavirus Infection

Since emerging in 2012, Middle East Respiratory Syndrome Coronavirus (MERS-CoV) has been a global public health threat with a high fatality rate and worldwide distribution. There are no approved vaccines or therapies for MERS until now. Passive immunotherapy with neutralizing monoclonal antibodies (...

Full description

Bibliographic Details
Main Authors:	Hui-Ju Han, Jian-Wei Liu, Hao Yu, Xue-Jie Yu
Format:	Article
Language:	English
Published:	MDPI AG 2018-11-01
Series:	Viruses
Subjects:	Middle East Respiratory Syndrome Virus MERS-CoV neutralizing monoclonal antibodies
Online Access:	https://www.mdpi.com/1999-4915/10/12/680

Similar Items

Serologic Detection of Middle East Respiratory Syndrome Coronavirus Functional Antibodies
by: Nisreen M.A. Okba, et al.
Published: (2020-05-01)

Sequential Emergence and Wide Spread of Neutralization Escape Middle East Respiratory Syndrome Coronavirus Mutants, South Korea, 2015
by: Yeon-Sook Kim, et al.
Published: (2019-06-01)

Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus
by: Daniel C. Payne, et al.
Published: (2016-10-01)

Middle East Respiratory Syndrome Coronavirus in Bats, Saudi Arabia
by: Ziad A. Memish, et al.
Published: (2013-11-01)

Characteristics of Traveler with Middle East Respiratory Syndrome, China, 2015
by: Wen Da Guan, et al.
Published: (2015-12-01)

Antibodies and vaccines against Middle East respiratory syndrome coronavirus
by: Jiuyang Xu, et al.
Published: (2019-01-01)

Middle East Respiratory Syndrome Coronavirus in Dromedaries in Ethiopia Is Antigenically Different From the Middle East Isolate EMC
by: Kazuya Shirato, et al.
Published: (2019-06-01)

Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea
by: Wan Beom Park, et al.
Published: (2015-12-01)

Stability of Middle East Respiratory Syndrome Coronavirus in Milk
by: Neeltje van Doremalen, et al.
Published: (2014-07-01)

Antibodies against MERS Coronavirus in Dromedary Camels, United Arab Emirates, 2003 and 2013
by: Benjamin Meyer, et al.
Published: (2014-04-01)

Experimental Infection and Response to Rechallenge of Alpacas with Middle East Respiratory Syndrome Coronavirus
by: Gary Crameri, et al.
Published: (2016-06-01)

Development of Middle East Respiratory Syndrome Coronavirus vaccines – advances and challenges
by: Heeyoun Cho, et al.
Published: (2018-02-01)

Selection and Characterization of Monoclonal Antibodies Targeting Middle East Respiratory Syndrome Coronavirus through a Human Synthetic Fab Phage Display Library Panning
by: Yoonji Kim, et al.
Published: (2019-07-01)

Sensitive and Specific Detection of Low-Level Antibody Responses in Mild Middle East Respiratory Syndrome Coronavirus Infections
by: Nisreen M.A. Okba, et al.
Published: (2019-10-01)

Middle East Respiratory Syndrome Coronavirus Transmission
by: Marie E. Killerby, et al.
Published: (2020-02-01)

Genetic Insights into the Middle East Respiratory Syndrome Coronavirus Infection among Saudi People
by: Hatem A. Abuelizz, et al.
Published: (2021-10-01)

Acute Middle East Respiratory Syndrome Coronavirus Infection in Livestock Dromedaries, Dubai, 2014
by: Sung Sup Park, et al.
Published: (2015-06-01)

Estimation of Severe Middle East Respiratory Syndrome Cases in the Middle East, 2012–2016
by: Justin J. O’Hagan, et al.
Published: (2016-10-01)

Diversity of Middle East respiratory syndrome coronaviruses in 109 dromedary camels based on full-genome sequencing, Abu Dhabi, United Arab Emirates
by: Mohammed Farouk Yusof, et al.
Published: (2017-01-01)

Current Status in Middle East Respiratory Syndrome Coronavirus
by: Ayşe Uyan, et al.
Published: (2016-12-01)

Surveillance and Testing for Middle East Respiratory Syndrome Coronavirus, Saudi Arabia, March 2016–March 2019
by: Abdullah Alzahrani, et al.
Published: (2020-07-01)

Lack of transmission among healthcare workers in contact with a case of Middle East respiratory syndrome coronavirus infection in Thailand
by: Surasak Wiboonchutikul, et al.
Published: (2016-05-01)

Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus
by: Timothy M. Uyeki, et al.
Published: (2016-07-01)

Ongoing Evolution of Middle East Respiratory Syndrome Coronavirus, Saudi Arabia, 2023–2024
by: Ahmed M. Hassan, et al.
Published: (2025-01-01)

Outbreak of Middle East Respiratory Syndrome Coronavirus in Camels and Probable Spillover Infection to Humans in Kenya
by: Isaac Ngere, et al.
Published: (2022-08-01)

Middle East Respiratory Syndrome Coronavirus during Pregnancy, Abu Dhabi, United Arab Emirates, 2013
by: Asim Malik, et al.
Published: (2016-03-01)

Epitope mapping of severe acute respiratory syndrome coronavirus 2 neutralizing receptor binding domain-specific monoclonal antibodies
by: Faezeh Maghsood, et al.
Published: (2022-09-01)

A dual-targeting approach using a human bispecific antibody against the receptor-binding domain of the Middle East Respiratory Syndrome Coronavirus
by: Ji Hyun Lee, et al.
Published: (2024-07-01)

Searching for animal models and potential target species for emerging pathogens: Experience gained from Middle East respiratory syndrome (MERS) coronavirus
by: Júlia Vergara-Alert, et al.
Published: (2017-06-01)

Exportations of Symptomatic Cases of MERS-CoV Infection to Countries outside the Middle East
by: Cristina Carias, et al.
Published: (2016-04-01)

Transmission of Middle East Respiratory Syndrome Coronavirus Infections in Healthcare Settings, Abu Dhabi
by: Jennifer C. Hunter, et al.
Published: (2016-04-01)

Contrasting Modes of New World Arenavirus Neutralization by Immunization-Elicited Monoclonal Antibodies
by: Weng M. Ng, et al.
Published: (2022-04-01)

Identification of a Neutralizing Monoclonal Antibody That Recognizes a Unique Epitope on Domain III of the Envelope Protein of Tembusu Virus
by: Shenghua Qu, et al.
Published: (2020-06-01)

Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis
by: Alaa Badawi, et al.
Published: (2016-08-01)

Neutralizing Monoclonal Antibody, mAb 10D8, Is an Effective Detoxicant against Abrin-a Both In Vitro and In Vivo
by: Zhi Li, et al.
Published: (2022-02-01)

Experience in the use of neutralizing monoclonal antibodies in kidney transplant recipients with COVID-19
by: I. G. Kim, et al.
Published: (2023-04-01)

Development of Coronavirus Treatments Using Neutralizing Antibodies
by: Saman Fouladirad, et al.
Published: (2021-01-01)

Characterization of two neutralizing monoclonal antibodies with conformational epitopes against porcine deltacoronavirus
by: Wan Lu, et al.
Published: (2025-01-01)

MERS-CoV Antibodies in Humans, Africa, 2013–2014
by: Anne M. Liljander, et al.
Published: (2016-06-01)

Protective efficacy of an RBD-based Middle East respiratory syndrome coronavirus (MERS-CoV) particle vaccine in llamas
by: Jordi Rodon, et al.
Published: (2022-06-01)